| |
|
|
 
Robert M. Wasserman, Director of Research
Mr. Wasserman has over twenty years experience in equity research,
specializing in the area of health care with a unique focus on companies
in the Southeastern US and Florida . Among the areas Mr. Wasserman has covered
are pharmaceuticals, medical devices, healthcare services and biotechnology.
Mr. Wasserman has analyzed and written on over 100 publicly traded health care companies.
Mr. Wasserman was the founder of the Research effort at Dawson James, and he has also served
as Director of Research for Jesup & Lamont, Senior Research Analyst for Craig-Hallum Capital Group and
Vice President-Research and Partner for Southeast Research Partners/Ryan Beck. Prior to entering the securities
industry, Mr. Wasserman was a management consultant with Peat, Marwick, Mitchell & Co., now KPMG Peat Marwick.
Mr. Wasserman was selected All-Star Healthcare analyst for 2000 by the Wall Street Journal,
and has appeared in a number of media outlets, including Business Week, Forbes, The New York Times and CNBC.
Mr. Wasserman received his Masters of Business Administration degree in Finance from the University of Chicago and
dual Bachelor of Science degrees in Management and Engineering from the Massachusetts Institute of Technology.
|
|
